Fda Regulatory Intent News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Fda Regulatory Intent. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Fda Regulatory Intent Today - Breaking & Trending Today

Phase 2 Trial Closure Clears a Path for Accelerated Development of Stenoparib in Ovarian Cancer

Published: May 3, 2024

A phase 2 trial of stenoparib in advanced recurrent ovarian cancer has been closed early to enable a follow-on trial with FDA regulatory intent.

Source: onclive.com

Related Topics:

Thomas JensenAllarity Therapeutics IncAllarity Therapeutics Drug ResponseAllarity TherapeuticsAccessed MayOvarian CancerFda Regulatory IntentTrial ClosurePhase 2 Trial